On 20–23 November 2018, Pavilion 2, Crocus Expo IEC, will host Pharmtech & Ingredients 2018, the 20th Anniversary International Exhibition of Equipment, Raw Materials and Technologies for Pharmaceutical Production. The event is organised by ITE Group being the leader in the Russian market of exhibition services.
Today, the volume of the Russian pharmaceutical market exceeds one trillion roubles (RUB 1.246 trillion); according to the results of 2017, Russian medicines captured over 30% of the market, and the total production volume at producer’s values reached 295 billion roubles. During eight years of implementation of Pharma 2020 State Programme, many production sites have undergone modernisation and technical reequipment. The total volume of investments into the industry has exceeded 150 billion roubles, and more than half of producers of medicines constituting the major share of the market have modernised their production. They have acquired technological competencies to produce medicines of most diverse complexity degrees: from generics to complex biotechnological products. Today, the industry enterprises’ agenda includes the development and further production of a new generation of drugs for therapy of oncological and cardiovascular diseases. Owing to the state support, 20 new pharmaceutical plants have already been opened, and production of medicines, in particular, molecules for therapy of HIV, tuberculosis, and diabetes mellitus, has been initiated.
Pharmtech & Ingredients today is a unique exhibition project being significant for the industry and promoting domestic production and cooperation between international innovators and Russian drug-makers.
In 2018, the number of companies participating in the exhibition has increased and reached 439 from 31 countries of the world. The display area has also increased by 9%, as compared to the previous year, and exceeded 18,000 sq.m. Over 130 companies are new participants of the exhibition and will present their displays for the first time. German and Swiss companies traditionally display their products as part of national pavilions. A collective exposition of companies from India and a collective exposition of API producers from China will be displayed at the exhibition for the first time.
The exhibitors’ stands will feature a broad range of production and packaging equipment, lab equipment, design and process solutions for creation of turnkey pharmaceutical production and “clean rooms”. Visitors will have an opportunity to see many exhibits in operation right at the stands. Ingredients section will feature Russian and international manufacturers of high-quality APIs and functional ingredients currently used to manufacture advanced drugs.
Hi-tech equipment innovations will be displayed at the exhibition. For example, GEA will demonstrate the operation of GEA ConsiGma® 1, a laboratory granulator; this device can be equipped with an additional segment for placement of a fluid-bed drier to carry out research and development.
The machine was developed to ensure maximum flexibility, simplify the procedure of R&D and formulation development. Its advantages include lean production, a flexible lot size, fast format change, convenient control elements, and some others. This equipment has been created to be used in processes of continuous production that is gaining momentum in pharmaceutical industry. Continuous production allows making more efficient use of medicines and switching from staged and time-consuming processing of lots to a fully integrated and controllable process that ensures excellent consistency of the product.
Mdi will present a wide choice of equipment and inventions used for sterilisation filtration, sterility testing, specimen products and active ingredients sample preparation, development of new drugs and formulations. The stand will also feature world-class membranes for development and production of rapid immunological tests. The assortment of membranes for blotting and sets for segregation and refining of nucleic acids will be interesting for life sciences research laboratories.
DARA Pharma will demonstrate a new machine for filling and capping of disposable dual-chamber syringes, bottles, and cartridges in sockets. The syringes, bottles, and cartridges are supplied ready for use, sterilised, and ready for filling, so they do not need preliminary washing, sterilisation or a special transportation system for movement between the processing operations.
MILK packaging factory, a large producer of blister foil, will present high-quality primary packaging manufactured jointly with Aluberg, an Italian producer of foil, in compliance with GMP requirements.
PharmTechnologies will present equipment of its own making: EVIO fermenter designed for aerobic and anaerobic cultivation of cells, high-viscosity, solid, semisolid, and liquid fermentation processes. Besides, the company is the exclusive distributor of such European companies as STE, KOCH Pac-Systeme, COOLVACUUM, and KIKUSUI. The stand will present the entire line of equipment for production of solid formulations by STE TECPHARM (Spain), a wide range of packing equipment by KOCH Pac-Systeme (Germany), vacuum freeze dryers by COOLVACUUM, a Spanish producer, as well as KIKUSUI tablet presses manufactured jointly by Japan and Italy.
Pharmtech & Ingredients traditionally includes a large programme of business events featuring the leading experts in pharmaceutical production, representatives of government regulatory agencies, and top managers of Russian and international companies. The subjects of roundtable discussions reflect the most pressing problems and challenges of the industry in the current year.
On 20 November, the business programme events will be opened by “Preliminary Results of the Medicines Labelling Pilot Project”, roundtable discussion, and the Association of Russian Pharmaceutical Manufacturers is acting as its co-organiser. The roundtable discussion will concern the issues related to medicines labelling, counteraction of illegal and counterfeit drugs sales, interim results of the pilot project for labelling with control (identification) signs and monitoring of sales of certain medication types, problems detected during the experiment and ways to overcome them, legal support, and rules of good practice of pharmacological surveillance within the Eurasian Economic Union. Anton Kharitonov, Pharma Product Area Manager at the Advanced Technologies Development Centre, Gennady Pyatsky, CEO at AstraZeneca Industries LLC, Vasily Ignatiev, CEO at R-Pharm, Ivan Glushkov, Deputy CEO at STADA CIS, Nikolay Polyansky, Deputy CEO of External Relations at CV PROTEK CJSC, are among the speakers.
“Technology Transfer: Best Practices of Russian and Foreign Manufacturers” roundtable discussion will take place on the same day. The roundtable discussion will deal with practical examples of technology transfer (including from a laboratory to a production site, from one production division of a company to another) successfully implemented by Russian and foreign pharmaceutical companies. Gennady Pyatsky, CEO at AstraZeneca Industries LLC, Alexander Rudko, CEO at R&D Centre of Novamedika Innotech, Ilya Vesker, Director for Government Relations at Takeda Russia, and Sergey Shulyak, CEO at DSM Group, will take part in the discussion. The roundtable discussion will be moderated by Liliya Titova, Executive Director of the Union of Professional Pharmaceutical Organisations. The Union of Professional Pharmaceutical Organisations and Kaluga Pharmaceutical Cluster are co-organisers of the event.
“Topical Issues of Low-Tonnage Chemistry Development for Pharmaceuticals and Related Industries” roundtable discussion will take place on 21 November. The event is organised jointly with the Ministry of Industry and Trade of the Republic of Tatarstan. Ramil Khabriev, Academic Adviser at Semashko National Research Institute of Public Health, Aleksey Savelchev, Deputy Minister of Industry and Trade of the Republic of Tatarstan, Rafinat Yarullin, CEO at Tatneftekhiminvest-Holding OJSC, Igor Narkevich, Principal at Saint-Petersburg State Chemical and Pharmaceutical Academy, and other experts in low-tonnage chemistry will take part in the roundtable discussion.
On 21 November, the work of Pharmtechprom, the 13th International Forum, will start. The forum will be held during two days. This year, the event is addressing new topics and is focused on innovations in the global pharmaceuticals. The programme of the forum includes four sessions during which Russian and international experts will present their reports:
- Session A: Raw Materials and Ingredients for Pharmaceutical Production
- Session B: Technologies and Equipment for Pharmaceutical Production
- Session C: Packaging Equipment and Materials
- Session D: Auxiliary Processes in Pharmaceutical Production
Renat Kashapov, Excipients and APIs Account Manager in Russia and CIS, Merck (Germany), Nadezhda Romanova, BASF (Russia), Sales and Technical Support Manager in Russia and CIS, Dirk Steinhauser, Deputy Director of Dresden Branch of Glatt Ingenieurtechnik GmbH (Germany), Stanislav Fradkin, CEO at Rohrer LLC (Russia), and other Russian and international experts will participate in the work of the forum.
“API Production: Problems and Solutions” roundtable discussion will take place on 22 November. The roundtable discussion will address problems related to production, importation, registration, and application of active pharmaceutical ingredients in Russia. The invited experts will discuss a number of issues associated with API manufacturing engineering, training of personnel for the manufacture, as well as a number of related problems. The roundtable discussion will be moderated by Victor Dmitriev, CEO at the Association of Russian Pharmaceutical Manufacturers, and Ivan Glushkov, Deputy CEO of Development at STADA CIS. Alexander Malin, CEO at NATIVA LLC, Alexander Semenov, President of Aktivnyi Komponent CJSC, Elena Sinchenko, Board Member at BION LLC, Alexey Nesterov, CEO at Permсhemical Company LLC, and other industry experts will take part in the discussion. The roundtable discussion is organised jointly with Reatorg, MediBalt, and STADA CIS. BION LLC is the event partner.
Pharmtech & Ingredients exhibition will traditionally include Pharmtech Tutor educational project.The objective of the project is to ensure the acquisition of practical skills by students of pharmaceutical educational institutions. 60 students of the leading Russian universities, including Peoples’ Friendship University of Russia, I.M. Sechenov First Moscow State Medical University, Moscow State University of Fine Chemical Technologies, Yaroslavl State Medical University, Yaroslavl State Technical University, Yaroslavl State University, Yaroslavl Industrial and Economic College, will be assisted by major international exhibitors in taking a mini-internship at the stands of the participating companies. 38 companies will be involved in Pharmtech Tutor project.